EA
MGNX icon

Emerald Acquisition’s MacroGenics MGNX Stock Holding History

Emerald Acquisition’s Portfolio MGNX Stock Details MGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		$780K Buy
+26,079
New +$776K ﹤0.01% 2252

Other funds holding MGNX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
BRC
Blue Ridge Capital New York $215M AUM
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Emerald Acquisition's MGNX Position: Q3 2016 in Review

Emerald Acquisition opened a new position in MacroGenics (MGNX) in Q3 2016: 26,079 shares worth $780K. The stake represents ﹤0.01% of the portfolio and ranks #2252 among its holdings.

132 funds tracked by Wall St. Rank hold MGNX as of Q3 2016.

  • Emerald Acquisition held 26,079 shares of MacroGenics worth $780K as of Q3 2016.
  • MacroGenics was a new Emerald Acquisition position in Q3 2016.
  • MacroGenics made up ﹤0.01% of Emerald Acquisition's portfolio in Q3 2016, its #2252 holding.
  • 132 funds tracked by Wall St. Rank held MacroGenics as of Q3 2016.

Based on Emerald Acquisition's 13F filing for Q3 2016, filed 9 Nov 2016.